Does the media refer more to COCH or VANI?

In the previous week, Envoy Medical and Envoy Medical both had 3 articles in the media. Vivani Medical's average media sentiment score of 0.25 beat Envoy Medical's score of -0.65 indicating that Vivani Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative Vivani Medical 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, PDEX or COCH?

Pro-Dex has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $74.64M 2.81 $8.98M $3.62 18.14 Envoy Medical $240K 241.22 -$23.76M -$0.76 N/A

Is PDEX or COCH more profitable?

Pro-Dex has a net margin of 16.08% compared to Envoy Medical's net margin of -11,304.83%. Pro-Dex's return on equity of 22.78% beat Envoy Medical's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 16.08% 22.78% 14.30% Envoy Medical -11,304.83% N/A -144.13%

Does the media prefer PDEX or COCH?

In the previous week, Envoy Medical had 1 more articles in the media than Pro-Dex. MarketBeat recorded 3 mentions for Envoy Medical and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat Envoy Medical's score of -0.65 indicating that Pro-Dex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative

Which has higher valuation & earnings, OWLT or COCH?

Envoy Medical has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Owlet $105.70M 1.45 -$39.68M -$0.75 N/A Envoy Medical $240K 241.22 -$23.76M -$0.76 N/A

Is OWLT or COCH more profitable?

Owlet has a net margin of -8.61% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Envoy Medical -11,304.83% N/A -144.13%

Does the media favor OWLT or COCH?

In the previous week, Owlet had 1 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for Owlet and 3 mentions for Envoy Medical. Owlet's average media sentiment score of 0.86 beat Envoy Medical's score of -0.65 indicating that Owlet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative

Is FOCL or COCH more profitable?

FocalTherics has a net margin of -56.26% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat FocalTherics' return on equity. Company Net Margins Return on Equity Return on Assets FocalTherics -56.26% -248.00% -44.69% Envoy Medical -11,304.83% N/A -144.13%

Does the media favor FOCL or COCH?

In the previous week, FocalTherics had 19 more articles in the media than Envoy Medical. MarketBeat recorded 22 mentions for FocalTherics and 3 mentions for Envoy Medical. FocalTherics' average media sentiment score of 1.25 beat Envoy Medical's score of -0.65 indicating that FocalTherics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FocalTherics 10 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media prefer KRMD or COCH?

In the previous week, Envoy Medical had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for Envoy Medical and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.00 beat Envoy Medical's score of -0.65 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative

Envoy Medical (COCH) Competitors

$0.75 0.00 (-0.05%)

As of 08/21/2026 04:00 PM Eastern

Compare

COCH vs. VANI, PDEX, OWLT, FOCL, and KRMD

Should you buy Envoy Medical stock or one of its competitors? Envoy Medical's main competitors and comparable companies include Vivani Medical (VANI), Pro-Dex (PDEX), Owlet (OWLT), FocalTherics (FOCL), and KORU Medical Systems (KRMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Envoy Medical compare to Vivani Medical?

Envoy Medical (NASDAQ:COCH) and Vivani Medical (NASDAQ:VANI) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-11,304.83%	N/A	-144.13%
Vivani Medical	N/A	-191.05%	-70.91%

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 7.1% of Envoy Medical shares are owned by insiders. Comparatively, 53.3% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	241.22	-$23.76M	-$0.76	N/A
Vivani Medical	N/A	N/A	-$26.61M	-$0.35	N/A

Envoy Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market.

Envoy Medical currently has a consensus target price of $2.00, indicating a potential upside of 166.67%. Vivani Medical has a consensus target price of $3.75, indicating a potential upside of 171.74%. Given Vivani Medical's stronger consensus rating and higher possible upside, analysts clearly believe Vivani Medical is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Envoy Medical and Envoy Medical both had 3 articles in the media. Vivani Medical's average media sentiment score of 0.25 beat Envoy Medical's score of -0.65 indicating that Vivani Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative
Vivani Medical	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Vivani Medical beats Envoy Medical on 9 of the 14 factors compared between the two stocks.

How does Envoy Medical compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

Pro-Dex has a beta of 0.02, suggesting that its share price is 98% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market.

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by company insiders. Comparatively, 7.1% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Envoy Medical had 1 more articles in the media than Pro-Dex. MarketBeat recorded 3 mentions for Envoy Medical and 2 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.71 beat Envoy Medical's score of -0.65 indicating that Pro-Dex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative

Pro-Dex has a net margin of 16.08% compared to Envoy Medical's net margin of -11,304.83%. Pro-Dex's return on equity of 22.78% beat Envoy Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
Envoy Medical	-11,304.83%	N/A	-144.13%

Pro-Dex currently has a consensus target price of $70.00, indicating a potential upside of 6.59%. Envoy Medical has a consensus target price of $2.00, indicating a potential upside of 166.67%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Pro-Dex has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$74.64M	2.81	$8.98M	$3.62	18.14
Envoy Medical	$240K	241.22	-$23.76M	-$0.76	N/A

Summary

Pro-Dex beats Envoy Medical on 12 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to Owlet?

Owlet (NYSE:OWLT) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

Owlet has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Owlet has a net margin of -8.61% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Envoy Medical	-11,304.83%	N/A	-144.13%

Envoy Medical has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.45	-$39.68M	-$0.75	N/A
Envoy Medical	$240K	241.22	-$23.76M	-$0.76	N/A

Owlet presently has a consensus price target of $15.00, indicating a potential upside of 186.81%. Envoy Medical has a consensus price target of $2.00, indicating a potential upside of 166.67%. Given Owlet's stronger consensus rating and higher probable upside, equities analysts plainly believe Owlet is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

72.6% of Owlet shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 7.1% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Owlet had 1 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for Owlet and 3 mentions for Envoy Medical. Owlet's average media sentiment score of 0.86 beat Envoy Medical's score of -0.65 indicating that Owlet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

Owlet beats Envoy Medical on 11 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

In the previous week, FocalTherics had 19 more articles in the media than Envoy Medical. MarketBeat recorded 22 mentions for FocalTherics and 3 mentions for Envoy Medical. FocalTherics' average media sentiment score of 1.25 beat Envoy Medical's score of -0.65 indicating that FocalTherics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FocalTherics	10 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative

FocalTherics currently has a consensus target price of $7.75, indicating a potential upside of 87.65%. Envoy Medical has a consensus target price of $2.00, indicating a potential upside of 166.67%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

FocalTherics has a net margin of -56.26% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Envoy Medical	-11,304.83%	N/A	-144.13%

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by insiders. Comparatively, 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

FocalTherics has a beta of -0.04, suggesting that its stock price is 104% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Envoy Medical has lower revenue, but higher earnings than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.19	-$29.25M	-$1.03	N/A
Envoy Medical	$240K	241.22	-$23.76M	-$0.76	N/A

Summary

FocalTherics beats Envoy Medical on 9 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

In the previous week, Envoy Medical had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for Envoy Medical and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.00 beat Envoy Medical's score of -0.65 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

KORU Medical Systems has a net margin of -4.03% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Envoy Medical	-11,304.83%	N/A	-144.13%

KORU Medical Systems has higher revenue and earnings than Envoy Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.58	-$2.64M	-$0.04	N/A
Envoy Medical	$240K	241.22	-$23.76M	-$0.76	N/A

KORU Medical Systems presently has a consensus price target of $7.00, suggesting a potential upside of 118.07%. Envoy Medical has a consensus price target of $2.00, suggesting a potential upside of 166.67%. Given Envoy Medical's higher probable upside, analysts clearly believe Envoy Medical is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

KORU Medical Systems has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market.

Summary

KORU Medical Systems beats Envoy Medical on 10 of the 16 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COCH vs. The Competition

Export

Metric	Envoy Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$57.90M	$6.02B	$7.37B	$12.85B
Dividend Yield	N/A	1.75%	2.53%	11.08%
P/E Ratio	-0.99	26.67	272.60	24.24
Price / Sales	241.22	45.38	618.96	99.81
Price / Cash	N/A	33.24	78.62	53.99
Price / Book	18.75	6.23	13.05	6.20
Net Income	-$23.76M	$150.07M	$3.47B	$348.59M
7 Day Performance	-6.25%	0.69%	2.09%	0.08%
1 Month Performance	13.46%	8.91%	6.64%	3.88%
1 Year Performance	-34.78%	8.07%	25.02%	16.98%

Envoy Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COCH Envoy Medical	2.0741 of 5 stars	$0.75 -0.1%	$2.00 +166.7%	-34.8%	$57.90M	$240K	N/A	34	News Coverage Analyst Forecast
VANI Vivani Medical	3.3428 of 5 stars	$1.36 -6.1%	$3.75 +175.5%	+11.3%	$118.14M	N/A	N/A	20
PDEX Pro-Dex	1.5494 of 5 stars	$66.80 -0.1%	$70.00 +4.8%	+42.7%	$213.35M	$66.59M	18.48	140	News Coverage
OWLT Owlet	3.2241 of 5 stars	$5.83 -0.3%	$15.00 +157.2%	-30.5%	$168.17M	$105.70M	N/A	106	News Coverage
FOCL FocalTherics	4.1115 of 5 stars	$4.37 +2.6%	$7.75 +77.3%	N/A	$163.79M	$70.53M	N/A	230	Earnings Report Upcoming Earnings High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COCH) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envoy Medical (COCH) Competitors

COCH vs. VANI, PDEX, OWLT, FOCL, and KRMD

How does Envoy Medical compare to Vivani Medical?

Summary

How does Envoy Medical compare to Pro-Dex?

Summary

How does Envoy Medical compare to Owlet?

Summary

How does Envoy Medical compare to FocalTherics?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envoy Medical (COCH) Competitors

COCH vs. VANI, PDEX, OWLT, FOCL, and KRMD

How does Envoy Medical compare to Vivani Medical?

Is COCH or VANI more profitable?

Do institutionals & insiders have more ownership in COCH or VANI?

Which has better valuation & earnings, COCH or VANI?

Which has more volatility and risk, COCH or VANI?

Do analysts prefer COCH or VANI?

Does the media refer more to COCH or VANI?

Summary

How does Envoy Medical compare to Pro-Dex?

Which has more volatility & risk, PDEX or COCH?

Do institutionals & insiders believe in PDEX or COCH?

Does the media prefer PDEX or COCH?

Is PDEX or COCH more profitable?

Do analysts recommend PDEX or COCH?

Which has better earnings & valuation, PDEX or COCH?

Summary

How does Envoy Medical compare to Owlet?

Which has more risk and volatility, OWLT or COCH?

Is OWLT or COCH more profitable?

Which has higher valuation & earnings, OWLT or COCH?

Do analysts recommend OWLT or COCH?

Do insiders & institutionals believe in OWLT or COCH?

Does the media favor OWLT or COCH?

Summary

How does Envoy Medical compare to FocalTherics?

Does the media favor FOCL or COCH?

Do analysts prefer FOCL or COCH?

Is FOCL or COCH more profitable?

Do insiders and institutionals believe in FOCL or COCH?

Which has more volatility and risk, FOCL or COCH?

Which has preferable valuation and earnings, FOCL or COCH?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Does the media prefer KRMD or COCH?

Do insiders and institutionals believe in KRMD or COCH?

Is KRMD or COCH more profitable?

Which has preferable earnings & valuation, KRMD or COCH?

Do analysts prefer KRMD or COCH?

Which has more risk and volatility, KRMD or COCH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools